Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$76.01 - $86.7 $19,990 - $22,802
-263 Reduced 6.87%
3,564 $274,000
Q1 2023

Apr 24, 2023

BUY
$77.31 - $88.08 $1,391 - $1,585
18 Added 0.47%
3,827 $317,000
Q4 2022

Jan 26, 2023

SELL
$62.32 - $89.47 $35,834 - $51,445
-575 Reduced 13.12%
3,809 $0
Q3 2022

Oct 14, 2022

SELL
$59.54 - $68.01 $26,435 - $30,196
-444 Reduced 9.2%
4,384 $270,000
Q2 2022

Jul 22, 2022

SELL
$57.72 - $65.01 $55,295 - $62,279
-958 Reduced 16.56%
4,828 $298,000
Q1 2022

May 06, 2022

SELL
$57.92 - $72.58 $26,990 - $33,822
-466 Reduced 7.45%
5,786 $343,000
Q4 2021

Feb 08, 2022

BUY
$64.88 - $73.64 $405,629 - $460,397
6,252 New
6,252 $453,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Granite Shares Advisors LLC Portfolio

Follow Granite Shares Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.